174 related articles for article (PubMed ID: 14707119)
21. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
Yankelevich B; Knobloch C; Nowicki M; Dennert G
J Immunol; 1989 May; 142(10):3423-30. PubMed ID: 2654290
[TBL] [Abstract][Full Text] [Related]
22. Activation of natural killer cells: underlying molecular mechanisms revealed.
Backström E; Kristensson K; Ljunggren HG
Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
[TBL] [Abstract][Full Text] [Related]
23. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
Vahlne G; Becker S; Brodin P; Johansson MH
Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
[TBL] [Abstract][Full Text] [Related]
24. Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.
Vitale C; Chiossone L; Morreale G; Lanino E; Cottalasso F; Moretti S; Dini G; Moretta L; Mingari MC
Mol Immunol; 2005 Feb; 42(4):405-11. PubMed ID: 15607791
[TBL] [Abstract][Full Text] [Related]
25. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
27. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
28. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
29. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.
Zhang C; Zhang J; Sun R; Feng J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jun; 5(6):1057-67. PubMed ID: 15829421
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation.
Vitale C; Chiossone L; Morreale G; Lanino E; Cottalasso F; Moretti S; Dini G; Moretta L; Mingari MC
Eur J Immunol; 2004 Feb; 34(2):455-60. PubMed ID: 14768050
[TBL] [Abstract][Full Text] [Related]
31. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
32. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
33. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
[TBL] [Abstract][Full Text] [Related]
34. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
[TBL] [Abstract][Full Text] [Related]
35. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
Ogasawara K; Benjamin J; Takaki R; Phillips JH; Lanier LL
Nat Immunol; 2005 Sep; 6(9):938-45. PubMed ID: 16086018
[TBL] [Abstract][Full Text] [Related]
36. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
Zhang T; Barber A; Sentman CL
Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
[TBL] [Abstract][Full Text] [Related]
37. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo.
Murphy WJ; Kumar V; Bennett M
Eur J Immunol; 1990 Aug; 20(8):1729-34. PubMed ID: 2209686
[TBL] [Abstract][Full Text] [Related]
39. Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens.
Bennett M; Kumar V; Mikhael A; Murphy WJ; Rembecki RM; Sentman CL; David CS
Transplant Proc; 1987 Dec; 19(6 Suppl 7):5-11. PubMed ID: 3321646
[No Abstract] [Full Text] [Related]
40. Molecular characterization of the novel rat NK receptor 1C7.
Bäckman-Petersson E; Miller JR; Hollyoake M; Aguado B; Butcher GW
Eur J Immunol; 2003 Feb; 33(2):342-51. PubMed ID: 12548565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
